A carregar...
Neoadjuvant and consolidation immuno-oncology therapy in stage III non-small cell lung cancer
Lung cancer continues to be the leading cause of cancer death worldwide. Recently, immunotherapy for non-small cell lung cancer (NSCLC) has emerged as a powerful treatment option for advanced lung cancer. The relative success of programmed death 1 (PD-1) and/or programmed death ligand 1 (PD-L1) anti...
Na minha lista:
| Publicado no: | J Thorac Dis |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AME Publishing Company
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5861269/ https://ncbi.nlm.nih.gov/pubmed/29593890 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2018.01.109 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|